Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Sensient Technologies
SXT
$5.3B
| $167M | 0.09% |
2,411,433
-56,730
| -2% | -$3.68M |
|
202
Carlisle Companies
CSL
$14.1B
| $166M | 0.09% |
424,387
-12,935
| -3% | -$4.39M |
|
203
Magnolia Oil & Gas
MGY
$5.55B
| $166M | 0.09% |
6,397,443
-84,289
| -1% | -$1.85M |
|
|
FOLD
204
DELISTED
Amicus Therapeutics
FOLD
| $163M | 0.09% |
13,814,514
+2,307,385
| +20% | +$29.5M |
|
205
Ardelyx
ARDX
$1.25B
| $161M | 0.09% |
22,048,006
-2,610,814
| -11% | -$22.3M |
|
206
Aptiv
APTV
$12.6B
| $158M | 0.09% |
1,982,469
+139,859
| +8% | +$11.3M |
|
207
Stellantis
STLA
$16.7B
| $158M | 0.09% |
5,518,060
+2,223,151
| +67% | +$55.4M |
|
208
American Electric Power
AEP
$72.4B
| $157M | 0.09% |
1,828,534
-992
| -0.1% | -$80.6K |
|
|
SWAV
209
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $157M | 0.09% |
480,665
-21,068
| -4% | -$5.17M |
|
210
Johnson & Johnson
JNJ
$643B
| $156M | 0.09% |
987,156
-317,853
| -24% | -$50.6M |
|
|
AKRO
211
DELISTED
Akero Therapeutics
AKRO
| $155M | 0.08% |
6,121,970
+1,815,569
| +42% | +$43.6M |
|
212
STAG Industrial
STAG
$7.79B
| $153M | 0.08% |
3,992,506
-140,408
| -3% | -$5.32M |
|
213
Euronet Worldwide
EEFT
$3.15B
| $153M | 0.08% |
1,390,895
+15,837
| +1% | +$1.66M |
|
214
Glaukos
GKOS
$8.89B
| $152M | 0.08% |
1,610,888
-5,646
| -0.3% | -$504K |
|
215
nVent Electric
NVT
$22.9B
| $152M | 0.08% |
2,010,512
-124,271
| -6% | -$7.98M |
|
216
AXIS Capital
AXS
$8.79B
| $151M | 0.08% |
2,321,271
+545,546
| +31% | +$32.7M |
|
217
Coca-Cola
KO
$380B
| $151M | 0.08% |
2,461,962
-779
| -0% | -$46.8K |
|
218
Vanguard Total International Stock ETF
VXUS
$153B
| $150M | 0.08% |
2,481,645
+10,648
| +0.4% | +$620K |
|
|
CCC
219
CCC Intelligent Solutions
CCC
$3.59B
| $149M | 0.08% |
12,469,424
+857,110
| +7% | +$9.78M |
|
|
ETNB
220
DELISTED
89bio
ETNB
| $147M | 0.08% |
12,603,382
+3,688,241
| +41% | +$40.8M |
|
221
United Therapeutics
UTHR
$26.1B
| $146M | 0.08% |
635,347
-234,772
| -27% | -$53M |
|
222
Verizon
VZ
$201B
| $145M | 0.08% |
3,453,075
+1,080,244
| +46% | +$43.6M |
|
223
Marriott International
MAR
$101B
| $142M | 0.08% |
564,666
-135,219
| -19% | -$32.7M |
|
224
ITT
ITT
$17.8B
| $140M | 0.08% |
1,026,762
-117,649
| -10% | -$14.6M |
|
225
IBM
IBM
$214B
| $137M | 0.07% |
717,202
+104,771
| +17% | +$19.1M |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.